Developer of medical device technologies and services to help patients suffering from vascular disease or structural heart defects selects the clinivation Global Enterprise Solution for Market Clearance Management as the foundation for managing their global market clearance operations.
Natick, MA, December 15, 2008 – clinivation, Inc. announced today that St. Jude Medical Cardiovascular Division has selected the the clinivation Global Enterprise Solution for Market Clearance Management enterprise solution for Market Clearance Management. “St. Jude Medical Cardiovascular Division is a leader in cardiovascular medical device technology, and we are pleased that they have selected the the clinivation Global Enterprise Solution for Market Clearance Management Market Clearance Platform as the foundation for managing their global market clearance operations,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions.
About the the clinivation Global Enterprise Solution for Market Clearance Management Market Clearance Platform
The the clinivation Global Enterprise Solution for Market Clearance Management enterprise solution for Market Clearance Management enables executives and their teams to address the challenges of execution, effective governance, and lean business performance in their global market clearance operations. By enabling excellence in global market clearance operations to advance the revenue intrinsic to market clearance success, the clinivation Global Enterprise Solution for Market Clearance Management liberates revenue that’s trapped-in-process.
About St. Jude Medical Cardiovascular Division
Headquartered in St. Paul, Minnesota, St. Jude Medical Cardiovascular Division offers technologies for treating patients with cardiovascular and peripheral vascular disease in three major areas: structural heart disease, carotid artery disease, and vascular access and closure. The division was a result of merging the Cardiac Surgery and Cardiology Divisions on January 1, 2007 in efforts to increase operating efficiencies and stimulate research and development. St. Jude Medical provides a growing portfolio of tissue valves, the industry’s gold standard mechanical heart valve and valve repair products to cardiac surgeons. The company offers vascular closure products and a developing pipeline of technologies to physicians performing interventional procedures.
For more information, please visit www.sjm.com.
About St. Jude Medical, Inc.
St. Jude Medical, Inc. is headquartered in St. Paul, Minnesota and employs approximately 12,000 people worldwide. They are dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. St. Jude Medical was named by Fortune Magazine’s “Most Admired Medical and Precision Equipment Company” in 2007 and 2008.
For more information, please visit www.sjm.com.
